Feb 02, 2026
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.37 to $0.02.
The split itself did not change the total investment value.
Atossa Therapeutics, Inc. (ATOS) trades on the NASDAQ Capital Market in the Biotechnology industry.
Atossa Therapeutics, Inc. company overviewThe latest split shown was on February 2, 2026. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 3 reverse splits between August 26, 2016 and February 2, 2026.